ADF improved insulin signaling and altered the proportion of α and β cells in obese mouse pancreases by reducing β cell apoptosis, increasing Akt (serine/threonine) phosphorylation, and improving diet-induced obesity islet tissue remodeling and β cell function [39]. Here, AKT1 is linked to obesity disorder.